switching to tirzepatide from Semaglutide Tirzepatide: Is It a Good Idea? Impact of the CVS GLP-1

Because IGFBP-3 limits the availability of IGF-1, which stimulates cellular growth and proliferation

128 Hence, for the treatment of obesity, OXM could provide a novel route for the development of therapeutic agents

This combination is therefore studied to better understand endocrine regulation of GH, IGF-1 production, metabolic response, the behavior of muscle and bone tissues, modulation of body composition in experimental models, and interactions between hypothalamic, pituitary, and peripheral signals

Patients report feeling a loss of control, shame, and frustration when weight returns despite their best efforts

JAMA 2009;301:1565-72.ArticlePubMedPMC 135

10.1016/j.exger.2017.12.005 [DOI] [PubMed] [Google Scholar] Smitha J